BPC-157

BPC-157 is a synthetic pentadecapeptide derived from human gastric juice that promotes angiogenesis, modulates the nitric oxide (NO) system, and upregulates growth hormone receptors and VEGFR2. It demonstrates cytoprotective and wound-healing properties across multiple tissue types including tendons, muscles, and the gastrointestinal tract.

• Accelerated tendon-to-bone healing in animal models
• Reduced recovery time from muscle tears and ligament injuries
• Gastrointestinal protective effects (ulcer healing)
• Promotes angiogenesis and new blood vessel formation
• Anti-inflammatory properties via NO pathway modulation
• Neuroprotective effects observed in preclinical studies

Research protocols typically use 250-500mcg daily via subcutaneous injection, often split into two doses. Oral formulations studied at 250mcg-500mcg for GI applications. Cycle lengths of 2-4 weeks are common in research settings.

Store lyophilized powder at -20°C. Reconstituted solution stable at 2-8°C for up to 30 days. Protect from light. Avoid freeze-thaw cycles.

BPC-157 has shown an excellent safety profile in animal studies with no reported toxicity at therapeutic doses. No significant adverse effects have been documented in published research literature.